ইঙ্গিত ও ব্যবহার
Xalaprost এর জন্য নির্দেশিত:
ডোজ নির্দেশিকা
শুধুমাত্র নির্দেশিকা তথ্য
প্রদর্শিত ডোজগুলি সরকারি উৎসের সাধারণ নির্দেশিকা। ব্যক্তিগতকৃত ডোজের জন্য সর্বদা আপনার ডাক্তার বা ফার্মাসিস্টের পরামর্শ নিন।
Adults:
The recommended dosage is 1 drop (1.5 mcg) in the affected eye(s) once daily in the evening.
পার্শ্বপ্রতিক্রিয়া
Eyelash changes (increased length, thickness, pigmentation, and number of lashes), darkening of the eyelid skin, intraocular inflammation (iritis/uveitis), changes in iris pigmentation, and macular edema, including cystoid macular edema, have been reported. In 6 month, multicenter, double masked, active controlled trials of Remaprost, 5 to 15% of patients experienced ocular adverse events and signs and symptoms such as blurred vision, burning and stinging, conjunctival hyperemia, a foreign body sensation, itching, increased iris pigmentation, and punctate epithelial keratopathy. Local conjunctival hyperemia was also observed; however, fewer than 1% of patients treated with Remaprost had to stop therapy because they could not tolerate this hyperemia.
সতর্কতা ও নিষেধাজ্ঞা
Warnings & Precautions
Ophthalmic Solution may cause the iris to gradually turn a darker shade over time. This happens because the melanocytes (pigment-producing cells) in the iris's stromal layer start producing more melanin, not because the number of these cells increases. In clinical trials, this browning effect did not continue to worsen after treatment was stopped, but the change in eye colour itself appears to be permanent. Some patients also notice darkening of the eyelid skin, which tends to fade back to normal once treatment ends. Eyelashes may become longer, thicker, more numerous, more pigmented, or grow in an irregular direction; these lash changes are usually reversible after stopping the medicine. This medicine should be used cautiously in patients with a history of intraocular inflammation (iritis or uveitis), and it is generally best avoided in those with active inflammation in the eye. Remaprost should also be used with caution in patients whose posterior lens capsule is not intact, or who have known risk factors for macular edema.
নিষেধাজ্ঞা
Known hypersensitivity to latanoprost, benzalkonium chloride, or any other ingredient in this product.